Nucleoside and nucleotide reverse transcriptase inhibitors
Stavudine; Lamivudine; Efavirenz
Composition
- Active ingredients
- STAVUDINE 40MG; LAMIVUDINE 150MG; EFAVIRENZ 600MG
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA022097.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Stavudine; Lamivudine; Efavirenz
- Active substance
- stavudine
- Drug class
- Nucleoside and nucleotide reverse transcriptase inhibitors, Antivirals for treatment of HIV infections, combinations
- Group
- Antivirals
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Strides Acrolab
- Status